Article
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
by
Sabrina Paganoni;
Suzanne Hendrix;
Samuel P Dickson;
Newman Knowlton;
Eric A Macklin;
James D Berry;
Micheal A Elliott;
Samuel Maiser;
Chafic Karam;
James B Caress;
Margaret A Owegi;
Adam Quick;
James Wymer;
Stephen A Goutman;
Daragh Heitzman;
Terry D Heiman-Patterson;
Carlayne E Jackson;
Colin Quinn;
Jeffrey D Rothstein;
Edward J Kasarskis;
Jonathan Katz;
Liberty Jenkins;
Shafeeq Ladha;
Timothy M Miller;
Stephen N Scelsa;
Tuan H Vu;
Christina Fournier;
Jonathan Glass;
Kristin M Johnson;
Andrea Swenson;
Namita A Goyal;
Gary L Pattee;
Patricia L Andres;
Suma Babu;
Marianne Chase;
Derek Dagostino;
Meghan Hall;
Gale Kittle;
Matthew Eydinov;
Michelle McGovern;
Joseph Ostrow;
Lindsay Pothier;
Randall Randall;
Jeremy M Shefner;
Alexender V Sherman;
Maria E St Pierre;
Eric Tustison;
Prasha Vigneswaran;
Jason Walker;
Hong Yu;
James Chan;
Janet Wittes;
Zi-Fan Yu;
Joshua Cohen;
Justin Klee;
Kent Leslie;
Rudolph E Tanzi;
Walter Gilbert;
Patrick D Yeramian;
David Schoenfeld;
Merit E Cudkowicz
2020